These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
575 related items for PubMed ID: 8754863
1. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice]. Rudoĭ NM. Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863 [Abstract] [Full Text] [Related]
2. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations]. Golyshevskaia VI, Sevast'ianova EV, Voronina GA. Probl Tuberk; 2001; (3):51-3. PubMed ID: 11508236 [Abstract] [Full Text] [Related]
3. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays]. Skotnikova OI, Galkina KIu, Nosova EIu, Krasnova MA, Moroz AM. Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020 [Abstract] [Full Text] [Related]
4. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A, Gogate A. Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525 [Abstract] [Full Text] [Related]
5. Drug-resistant tuberculosis in Budapest. Fodor T, Vadász I, Lõrinczi I. Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927 [Abstract] [Full Text] [Related]
6. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease]. Vishnevskiĭ BI, Steklova LN. Probl Tuberk Bolezn Legk; 2008 Sep; (12):5-8. PubMed ID: 19227317 [Abstract] [Full Text] [Related]
7. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis]. Firsova VA, Rusakova LI, Grigor'eva ZP, Ryzhova AP, Iatskova TV, Poluéktova FG. Probl Tuberk; 2001 Sep; (1):28-30. PubMed ID: 11337776 [Abstract] [Full Text] [Related]
8. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing. Pfyffer GE. Schweiz Med Wochenschr; 2000 Dec 09; 130(49):1909-13. PubMed ID: 11153397 [Abstract] [Full Text] [Related]
9. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis]. Vasil'eva IA, Chernousova LN, Zasedatelev AS, Sobolev AIu, Mikhaĭlovich VM. Probl Tuberk; 2002 Dec 09; (6):21-4. PubMed ID: 12227044 [Abstract] [Full Text] [Related]
10. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA. Int J Infect Dis; 2009 Sep 09; 13(5):e236-40. PubMed ID: 19285897 [Abstract] [Full Text] [Related]
11. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico. Zazueta-Beltran J, Muro-Amador S, Flores-Gaxiola A, Llausas-Magaña E, León-Sicairos N, Canizalez-Roman A. J Infect; 2007 Apr 09; 54(4):411-2. PubMed ID: 16730800 [No Abstract] [Full Text] [Related]
12. Primary drug resistant tuberculosis in Puerto Rico. Zack MB, Figueroa-Lebrón RE. Bol Asoc Med P R; 1974 Nov 09; 65(11):262-6. PubMed ID: 4217187 [No Abstract] [Full Text] [Related]
13. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000]. Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H. Arch Inst Pasteur Madagascar; 2002 Nov 09; 68(1-2):44-7. PubMed ID: 12643091 [Abstract] [Full Text] [Related]
14. [Occurence of primary resistance in hospital patients with respiratory tuberculosis]. Serdarević H, Bogdanović M, Travnik H, Simeonov L. Tuberkuloza; 1966 Nov 09; 18(1-3):220-7. PubMed ID: 16296090 [No Abstract] [Full Text] [Related]
15. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent]. Shaĭkhaev AIa, Naumov VN. Probl Tuberk; 2000 Nov 09; (4):24-6. PubMed ID: 10981427 [Abstract] [Full Text] [Related]
16. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates]. Zhukova MP. Probl Tuberk; 1998 Nov 09; (4):4-5. PubMed ID: 9771024 [Abstract] [Full Text] [Related]
17. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin]. Isakova ZhT, Pak OA, Iusupova EIu, Myrzaliev BB, Chubakov TCh, Goncharova ZA, Tumashova AF, Kozhomkulov MD, Kozhomkulov DK, Alisherov ASh, Friedland J, Aldashev AA. Probl Tuberk Bolezn Legk; 2005 Nov 09; (8):50-3. PubMed ID: 16209022 [Abstract] [Full Text] [Related]
18. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis]. Zierski M. Tuberkuloza; 1966 Nov 09; 18(1-3):300-6. PubMed ID: 16296101 [No Abstract] [Full Text] [Related]
19. Drug resistant tuberculosis in Estonia. Kruuner A, Sillastu H, Danilovitsh M, Levina K, Svenson SB, Källenius G, Hoffner SE. Int J Tuberc Lung Dis; 1998 Feb 09; 2(2):130-3. PubMed ID: 9562123 [Abstract] [Full Text] [Related]
20. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi GD, Mehta P, Mehta A. Clin Infect Dis; 2003 Jun 15; 36(12):e152-4. PubMed ID: 12802779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]